EDA2R and plasma cell myeloma: They found that elevated levels of EDA2R protein were positively associated with diffuse lymphoma, liver cancer, lung cancer, multiple myeloma, non‐Hodgkin lymphoma, lip and oral cavity cancer, lung adenocarcinoma, lung small cell carcinoma and lung squamous cell carcinoma.